Resof Total Tablets

Resof Total Tablets Specification

Indication
Chronic Hepatitis C Virus (HCV) infection

Dosage Form
Tablet

Origin
India

Salt Composition
Sofosbuvir 400 mg + Velpatasvir 100 mg

Enzyme Types
Resof Total Tablets

Feature
Fixed-dose combination, once-daily oral administration

Ingredients
Sofosbuvir, Velpatasvir, Excipients

Application
Antiviral therapy for HCV

Physical Color/Texture
Film-coated tablet, light yellow to yellow color

Fermentation Smell
Odorless

Storage Instructions
Cool & Dry Place

Shelf Life
24 months

Therapeutic Area
Antiviral, Hepatology

Approval
USFDA and DCGI approved

Route of Administration
Oral

Packing Type
Box of 28 tablets (4 strips of 7 tablets)

Drug Class
Direct-Acting Antiviral (DAA)

Patient Category
Adults

Common Side Effects
Headache, fatigue, nausea

Prescription Status
Prescription only

Precautions
Not recommended for use in pediatric patients, pregnancy consult required

Contraindications
Hypersensitivity to active ingredients

Resof Total Tablets Trade Information

Minimum Order Quantity
10 Pieces

Supply Ability
100 Pieces Per Day

Delivery Time
2 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About Resof Total Tablets

Resof Total 400mg/100mg Tablet is used in the treatment of chronic hepatitis C virus (HCV) infection.Resof Total 400mg/100mg Tablet is a combination of two antiviral medicines Sofosbuvir and Velpatasvir. They work by lowering the amount of hepatitis C virus in the body and removing the virus from the blood over a period of time.

Comprehensive HCV Antiviral Solution

Resof Total Tablets offer an advanced antiviral therapy designed for adults with chronic Hepatitis C. The fixed-dose combination of Sofosbuvir and Velpatasvir provides a powerful, once-daily treatment that streamlines patient care and promotes adherence. Its proven efficacy and international regulatory approvals underscore its value for global healthcare providers and patients alike.

Efficient Dosage and Administration

Each box of Resof Total Tablets contains 28 film-coated tablets, conveniently packaged into 4 strips. The oral tablets are easy to administer-simply take one tablet daily with or without food. This straightforward dosing, combined with the 24-month shelf life, supports practical storage and ensures consistent therapy for users.

FAQ's of Resof Total Tablets:

Q: How should Resof Total Tablets be used for treating Hepatitis C?

A: Resof Total Tablets should be taken orally, once daily, exactly as prescribed by your healthcare provider. Swallow the tablet whole with water, with or without food. Do not alter the dosage unless instructed by your physician.

Q: What is the main benefit of using Resof Total Tablets?

A: The main benefit is effective antiviral therapy for chronic Hepatitis C Virus (HCV) infection in adults, combining two potent agents (Sofosbuvir and Velpatasvir) to achieve high cure rates with a convenient, fixed-dose, once-daily regimen.

Q: When should I avoid taking Resof Total Tablets?

A: You should avoid Resof Total Tablets if you have a known hypersensitivity to Sofosbuvir, Velpatasvir, or any excipients. Consult your doctor if you are pregnant, planning pregnancy, or have any other medical conditions before starting treatment.

Q: What common side effects may occur with Resof Total Tablets?

A: Some patients may experience headache, fatigue, or nausea. If these effects persist, worsen, or if you notice anything unusual, notify your healthcare professional promptly.

Q: Where should Resof Total Tablets be stored?

A: Store the tablets in a cool, dry place away from direct sunlight and moisture. Always keep them out of reach of children and do not use after the expiry date.

Q: What precautions must be considered before starting Resof Total Tablets?

A: Resof Total Tablets are not recommended for pediatric patients. Women should consult their healthcare provider regarding use during pregnancy. Inform your physician about all medications you are taking to avoid potential drug interactions.

Q: Who are the intended patients for Resof Total Tablets?

A: This medication is intended for adults diagnosed with chronic HCV infection as prescribed and supervised by qualified healthcare professionals in antiviral and hepatology settings.

Tell us about your requirement